Yiwei Liu
No. 507, Zheng Min Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 31, 2025
Correction: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
Journal: BMC medicine
Published: September 20, 2024
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
Journal: BMC medicine
Published: July 08, 2023
Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation.
Journal: Chinese medical journal
Published: March 15, 2023
High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.
Journal: Translational lung cancer research
Published: April 23, 2021
Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer-an option for overcoming EGFR-TKI resistance.
Journal: Translational lung cancer research
Published: April 23, 2021
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations.
Journal: Translational lung cancer research
Published: March 15, 2021
Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.
Journal: Cancer management and research
Published: January 21, 2021
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors.
Journal: Translational lung cancer research
Published: September 21, 2020
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.
Journal: Cancer immunology, immunotherapy : CII
Published: September 15, 2020
Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 09, 2019
Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 20, 2019
Last Updated: 09/26/2026